Validation of a Multiplex Molecular Macroarray for the Determination of Allergen-Specific IgE Sensitizations in Dogs
- PMID: 39453074
- PMCID: PMC11512340
- DOI: 10.3390/vetsci11100482
Validation of a Multiplex Molecular Macroarray for the Determination of Allergen-Specific IgE Sensitizations in Dogs
Abstract
Detecting IgE sensitizations in the serum of allergic dogs is commonly performed using allergen extracts, but these are difficult to standardize. This article details the development and validation of the Pet Allergy Xplorer (PAX; Nextmune, Stockholm, Sweden), the first multiplex macroarray for the detection of IgE sensitization in dogs using allergen extracts and molecular components; the PAX is derived from the Allergy Xplorer (ALEX2; MacroArray Diagnostics, Vienna, Austria). The selection of allergens, cartridge processing, strategy for identifying and blocking IgE directed against cross-reactive carbohydrate determinants (CCDs), and the method used for determining the positivity threshold are described. The validation of the PAX included evaluations of the specificity of its anti-IgE monoclonal antibody, specificity of IgE binding to target allergens, assay precision, and internal consistency. Additionally, the influence of possible confounding factors, such as sample type, the influence of hemolysis, lipemia, bilirubinemia, and elevated CCD-IgE, was tested. Finally, the sensitization rates of 23,858 European dogs to 145 environmental and Hymenoptera venom allergens were summarized. The PAX is accurate and reproducible and has a unique CCD-detection and blocking strategy; its molecular allergens offer a unique window on allergen cross-reactivity.
Keywords: IgE; allergen; allergy; atopic dermatitis; dog; molecular allergology; serodiagnosis; serology.
Conflict of interest statement
T.O. and A.M.F. work for Nextmune, which commercializes the PAX, while M.A., N.P.I., G.M., and C.H. are employed by MacroArray Diagnostics, which manufactures both ALEX2 and the PAX.
Figures
Similar articles
-
Multiplex Assays in Allergy Diagnosis: Allergy Explorer 2 versus ImmunoCAP ISAC E112i.Diagnostics (Basel). 2024 May 8;14(10):976. doi: 10.3390/diagnostics14100976. Diagnostics (Basel). 2024. PMID: 38786274 Free PMC article.
-
Cross-reactive carbohydrate determinants in atopic and healthy dogs and their influence on allergy test specificity.Vet Rec. 2023 Nov 18;193(10):e3308. doi: 10.1002/vetr.3308. Epub 2023 Aug 24. Vet Rec. 2023. PMID: 37614212
-
Big Data-Driven Evolution of a Diagnostic Multiplex IgE-Test: Enhancing Accuracy and Efficacy in Allergy Diagnostics.Int J Mol Sci. 2025 Apr 29;26(9):4249. doi: 10.3390/ijms26094249. Int J Mol Sci. 2025. PMID: 40362486 Free PMC article.
-
Diagnostic reliability considerations of specific IgE determination.J Investig Allergol Clin Immunol. 1996 May-Jun;6(3):152-61. J Investig Allergol Clin Immunol. 1996. PMID: 8807505 Review.
-
Glycans and glycan-specific IgE in clinical and molecular allergology: Sensitization, diagnostics, and clinical symptoms.J Allergy Clin Immunol. 2017 Aug;140(2):356-368. doi: 10.1016/j.jaci.2017.04.019. Epub 2017 May 4. J Allergy Clin Immunol. 2017. PMID: 28479330 Review.
References
LinkOut - more resources
Full Text Sources
